Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11,988 GBX | -0.32% | +9.52% | +13.09% |
04-26 | ASTRAZENECA : DZ Bank sticks Neutral | ZD |
04-26 | ASTRAZENECA : UBS keeps a Sell rating | ZD |
Sales 2024 * | 51.18B 4,097B | Sales 2025 * | 54.76B 4,384B | Capitalization | 231B 18,531B |
---|---|---|---|---|---|
Net income 2024 * | 8.52B 682B | Net income 2025 * | 10.2B 816B | EV / Sales 2024 * | 4.91 x |
Net Debt 2024 * | 19.9B 1,593B | Net Debt 2025 * | 13.44B 1,076B | EV / Sales 2025 * | 4.47 x |
P/E ratio 2024 * |
27.2
x | P/E ratio 2025 * |
22.9
x | Employees | 89,900 |
Yield 2024 * |
2.09% | Yield 2025 * |
2.18% | Free-Float | 96.5% |
Latest transcript on AstraZeneca PLC
1 day | -0.32% | ||
1 week | +9.52% | ||
Current month | +12.27% | ||
1 month | +11.60% | ||
3 months | +13.67% | ||
6 months | +18.41% | ||
Current year | +13.09% |
Managers | Title | Age | Since |
---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 63 | 30/09/12 |
Aradhana Sarin
DFI | Director of Finance/CFO | 50 | 31/07/21 |
Cindy Hoots
CTO | Chief Tech/Sci/R&D Officer | 56 | 31/12/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sherilyn McCoy
BRD | Director/Board Member | 65 | 30/09/17 |
Ahmed Hamdy
PRN | Corporate Officer/Principal | 59 | 31/01/13 |
Philip Broadley
BRD | Director/Board Member | 63 | 26/04/17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
9.20% | 11 M€ | +0.83% | - | |
5.39% | 192 M€ | +13.43% | ||
5.17% | 18 M€ | +3.79% | - | |
4.89% | 776 M€ | +9.34% |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 11,988 | -0.32% | 2,360,261 |
25/04/24 | 12,026 | +5.94% | 4,952,967 |
24/04/24 | 11,352 | +0.75% | 3,596,131 |
23/04/24 | 11,268 | +0.16% | 3,561,073 |
22/04/24 | 11,250 | +2.78% | 3,448,159 |
Delayed Quote London S.E., April 26, 2024 at 04:35 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.09% | 231B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B | |
-11.77% | 144B |
- Stock Market
- Equities
- AZN Stock